Merrimack Reports First Quarter 2022 Financial Results

Author's Avatar
May 05, 2022

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2022 financial results for the period ended March 31, 2022.